Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Update

$AC Immune (ACIU.US)$ AC Immune Says Active-Immunotherapy Candidate, ACI-35.030 (Now Called JNJ-2056), Targeting Pathologic Form Of Tau Protein Has Received Fast Track Designation From FDA
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
1
+0
5
Translate
Report
3715 Views
Comment
Sign in to post a comment